webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid

  CAS No.:   Cat No.: BADC-00467   Purity: ≥98% 4.5  

1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid is a small molecule pharmaceutical compound with potential therapeutic effect on a variety of diseases, including inflammation , cancer and metabolic disorders. This compound uniquely modulates the complex molecular cascades that underlie the onset and progression of these diseases.

1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid

Structure of

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C15H18N2O7S3
Molecular Weight
434.51

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid;
Appearance
Soild powder

Pharmaceutical Development: The compound 1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid is being investigated for its potential therapeutic applications in drug development. Its unique structure allows it to interact with various biological targets, making it a candidate for the development of novel pharmaceuticals aimed at treating specific diseases. Researchers are exploring its mechanisms of action and pharmacokinetics to determine its efficacy and safety profiles. The ability to modulate specific pathways can lead to advancements in targeted therapies and personalized medicine.

Antioxidant Properties: This compound exhibits notable antioxidant properties, which can be harnessed in various industrial applications. By scavenging free radicals, it can help mitigate oxidative stress in biological systems, making it valuable in formulations for health supplements, cosmetics, and food preservation. The integration of 1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid into these products could enhance their effectiveness and stability, leading to improved health outcomes and prolonged shelf life.

Bioconjugation Applications: The compound's functional groups lend themselves well to bioconjugation processes, which are essential in the creation of biomaterials and drug delivery systems. Its ability to form stable linkages with various biomolecules enables the development of targeted delivery systems for therapeutics, including antibody-drug conjugates. This application is particularly significant in oncology, where precise targeting of cancer cells can reduce side effects and enhance treatment efficacy. The versatility of this compound makes it a valuable tool in bioconjugate chemistry.

Analytical Chemistry: In the realm of analytical chemistry, 1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid serves as a reagent for detecting and quantifying specific biomolecules. Its distinctive structure allows for the development of sensitive assays that can be used in research laboratories and clinical settings. By facilitating the detection of target analytes, this compound plays a crucial role in advancing diagnostic methodologies, thereby improving disease monitoring and management strategies. Its utility in high-throughput screening processes also contributes to accelerated drug discovery efforts.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: 1-(4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid | MC-Alkyl-Hydrazine Modified MMAF | Cys-MC-MMAF | Indatuximab ravtansine | PEG4-aminooxy-MMAF | sulfo-SPDB-DM4 | Sulfo-PDBA-DM4 | DM4-SPDB | S-Me-DM4 | Deruxtecan | 1-(4-methyl-4-(pyridin-2-yldisulfanyl)pentanoyloxy)-2,5-dioxopyrrolidine-3-sulfonic acid
Send Inquiry
Verification code
Inquiry Basket